Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Home
<
List for "Lenalidomid Sandoz 2.5 mg"
<
Preisvergleich für Tineafin 125 mg
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Registr. Holder
Package Size
Composition
CP
%
SB
DC
IP
CI
Tineafin 125 mg
Bailleul (Suisse) SA
14 Tablet(s)
Tablets: Terbinafinum 125 mg
34.05
k.A.
IP
CI
Terbinafin-Mepha 125
Mepha Pharma AG
14 Tablet(s)
Tablets: Terbinafinum 125 mg
29.50
-13%
10 %
IP
CI
Terbinax 125 mg
Drossapharm AG
14 Tablet(s)
Tablets: Terbinafinum 125 mg
29.50
-13%
10 %
IP
CI
Terbifil 125
Sandoz
Pharmaceuticals AG
14 Tablet(s)
Tablets: Terbinafinum 125 mg
33.65
-1%
10 %
IP
CI
Lamisil 125 mg
Novartis Pharma
Schweiz AG
14 Tablet(s)
Tablets: Terbinafinum 125 mg
41.50
+21%
10 %
IP
CI
Terbinafin Axapharm 125 mg
axapharm ag
14 Tablet(s)
Tablets: Terbinafinum 125 mg
PR
k.A.
IP
CI
Terbinafin Zentiva 125 mg
Helvepharm AG
14
Tablets: Terbinafinum 125 mg
PR
k.A.
For price comparison between Original and Generic please click onto the name of the drug all the way to the left!
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2024
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home
